The company in question is, Smith & Nephew plc (NYSE:SNN) currently with a stock price of 32.71 (-1.06% today). The market cap for Smith & Nephew plc is 14799.97, and is in the sector Healthcare, and Medical Appliances & Equipment industry. The target price for Smith & Nephew plc is 41. Currently Smith & Nephew plc is trading with a P/E of 41.64, and a forward P/E of 17.4. Average volume for Smith & Nephew plc is 419.43 and so far today it is 27628.
Performance in the last year for Smith & Nephew plc has been -6.92%. For EPS growth, Smith & Nephew plc has seen a growth of -18.20%, and is looking to grow in the next year to 13.98%. More long term stats show that EPS growth has been -7.80% over the last five years and could be 7.10% for the next five years. Smith & Nephew plc has seen sales growth quarter over quarter at 2.50%, with EPS growth quarter over quarter at -18.30%. The 20-day simple moving average is -2.99%, with the 200-day simple moving average coming to -1.80%.
Since the IPO date for Smith & Nephew plc on the 11/16/1999, Smith & Nephew plc has seen performance year to date to be -6.11%. With Smith & Nephew plc trading at 32.71, the dividend yield is 1.48%, and the EPS is 0.79.
So could Smith & Nephew plc, be undervalued? Well as said before P/E is 41.64. The PEG is 5.86, P/S is 3.16 and the P/B is at 3.75. The P/cash is 174.12, with P/free cash flow at *TBA.
Smith & Nephew plc ability to deal with debt shows that the current ratio is 1.9, and the quick ratio is 0.9. This is with long term debt/equity at 0.43, and total debt/equity at 0.45.
In terms of margins, Smith & Nephew plc has a gross margin of 74.20%, an operating margin of *TBA and a profit margin of *TBA.Payout ratio for Smith & Nephew plc is *TBA. Return on assets come to *TBA with return on investment coming to 8.80%.
Insider ownership for Smith & Nephew plc, is at 0.60% and institutional ownership comes to 5.90%. Outstanding shares are at 447.67. While shares float is 441.85. The float short is currently 0.28%, and short ratio is 2.93.